Drug
Who makes alvimopan?
3 companies list alvimopan as a human prescription drug. Forms: capsule. Routes: oral.
Labellers from the openFDA NDC Directory. A labeller is the firm named on the label, not necessarily the site that made the product, and a listing is not an FDA approval. Data as of 24 Sept 2026. Methodology
Companies listing alvimopan
| Company | Forms | Application | NDCs | Registered sites |
|---|---|---|---|---|
| Par Health USA, LLCIndia | capsule | ANDAANDA216843 | 1 | 5 |
| Hikma Pharmaceuticals USA Inc.United States | capsule | ANDAANDA217753 | 1 | 4 |
| Golden State Medical Supply Inc.United States | capsule | ANDAANDA217753 | 1 | 1 |
Orange Book patents
1 unexpired patent lists alvimopan as the active ingredient, expiring between Feb 2030 and Feb 2030. Application holder: CUBIST PHARMACEUTICALS INC.
Enquiry
Common questions
- Who makes alvimopan?
- 3 companies list alvimopan as a human prescription drug in the openFDA NDC Directory, led by Par Health USA, LLC, Hikma Pharmaceuticals USA Inc., Golden State Medical Supply Inc.. Each is the labeller, the firm named on the label; the product may be made at a site registered to another company.
- Is there a generic alvimopan?
- 3 companies list alvimopan under an abbreviated new drug application (ANDA), the application type used for generics. Listing status is from the NDC Directory; it is not a statement of availability.